Abstract

The inflammatory bowel diseases (IBDs) are chronic immune-mediated inflammatory disorders, including ulcerative colitis (UC) and Crohn’s disease (CD). IBD results from a complex interplay between environmental, microbial, and genetic factors to create an abnormal immunological response leading to intestinal inflammation.

Tags

Inflammatory Bowel Disease, IBD, Drug Therapy, therapeutic use, Antibodies, Monoclonal

Read More